Latest Biotech News

Lonza's Synaffix platform has entered a licensing collaboration with Qurient Therapeutics to develop a novel dual-payload antibody-drug conjugate (ADC) integrating Synaffix’s exatecan technology...

Multiple research breakthroughs offer promising solutions for sustainable agriculture under climate challenges. A fully biodegradable hydrogel supports soilless farming in drought conditions,...

UniQure announced positive topline data from its pivotal phase I/II trial evaluating AMT-130 for Huntington’s disease (HD), demonstrating statistical significance in slowing disease progression by...

Hansa Biopharma reported positive outcomes from a pivotal U.S. phase III trial of imlifidase, an enzyme that rapidly cleaves antibodies to facilitate kidney transplantation in highly sensitized...

The U.S. Food and Drug Administration approved Eli Lilly’s oral selective estrogen receptor degrader (SERD), Inluriyo (formerly imlunestrant), for adults with metastatic, estrogen...

Researchers from Mass General Brigham and the Broad Institute employed in vivo CRISPR screening to identify gene knockouts that significantly improve CAR T cell function and persistence against...

A University of Washington-led team, including Nobel Laureate David Baker, developed a generalizable molecular on/off protein switch that modulates binder dissociation rates by up to 6,000-fold,...

Scientists at Howard Hughes Medical Institute uncovered a mechanism explaining how longevity traits are inherited across generations in C. elegans. Lysosomal metabolic changes in parent worms...

Researchers at the Arc Institute and University of California, Berkeley have engineered RNA-guided bridge recombinases to perform massive, programmable human genome rearrangements spanning...

Following the announcement of AMT-130’s robust slowing of Huntington’s disease progression at 36 months, UniQure’s stock surged over 200%, reflecting strong market confidence. The trial met both...

Lonza’s Synaffix platform entered a licensing agreement with South Korea’s Qurient Therapeutics to develop a clinical-stage dual-payload antibody-drug conjugate (ADC) targeting solid tumors. The...

Claritas Rx unveiled its Access Analytics platform to address fragmented data in market access operations for commercial life science companies. The software consolidates real-time data from...

Uniqure announced a landmark success with its gene therapy AMT-130 demonstrating a 75% slowing of Huntington’s disease progression at 36 months, based on a pivotal Phase I/II study. The therapy...

The FDA granted approval to Eli Lilly’s Inluriyo (imlunestrant), an oral selective estrogen receptor degrader (SERD) for advanced breast cancer patients harboring ESR1 mutations. The decision is...

Hansa Biopharma reported positive Phase 3 trial results for imlifidase, an enzyme that cleaves antibodies to enable kidney transplants for highly sensitized patients on dialysis. The trial showed...

Researchers at Mass General Brigham and the Broad Institute have employed CRISPR screening to identify gene knockouts that improve T cell function and persistence in chimeric antigen receptor...

Biomedical engineers at Duke University developed an integrated AI-driven platform combining automated wet lab processes with artificial intelligence to rapidly design nanoparticles optimized for...

Cytosurge and Lexogen have launched a live-cell sequencing workflow integrating FluidFM cytoplasmic sampling and ultra-sensitive RNA library preparation to enable repeated transcriptomic profiling...

A team at the University of Washington developed a novel protein on/off switch leveraging AI-guided design to facilitate rapid dissociation kinetics, accelerating cytokine signaling modulation by...

Researchers have engineered a copper oxide and barium oxide (CuO/BaO) nanocomposite exhibiting superior pseudocapacitive performance for next-generation energy storage applications. Synthesized...